MergerLinks Header Logo

Announced

Molex to acquire Vectura Group from Philip Morris International for £298m.

Synopsis

Molex, a manufacturer of electronic, electrical, and fiber optic connectivity systems, agreed to acquire Vectura Group, a British pharmaceuticals company which develops inhaled medicines and makes inhaler devices, from Philip Morris International, an American multinational tobacco company, for £298m. “The acquisition of Vectura is the latest step in building an industry-leading capability in medical. It also demonstrates Molex’s commitment to acquiring opportunities to better serve market needs across our portfolio," Joe Nelligan, Molex CEO.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US